1. Home
  2. MXL vs VIR Comparison

MXL vs VIR Comparison

Compare MXL & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxLinear Inc.

MXL

MaxLinear Inc.

HOLD

Current Price

$19.01

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$7.28

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXL
VIR
Founded
2003
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
MXL
VIR
Price
$19.01
$7.28
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$19.80
$28.63
AVG Volume (30 Days)
1.3M
1.9M
Earning Date
01-29-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$467,641,000.00
$16,860,000.00
Revenue This Year
$18.98
N/A
Revenue Next Year
$12.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
29.71
N/A
52 Week Low
$8.35
$4.16
52 Week High
$20.82
$10.67

Technical Indicators

Market Signals
Indicator
MXL
VIR
Relative Strength Index (RSI) 54.69 54.03
Support Level $16.11 $6.86
Resistance Level $18.27 $7.97
Average True Range (ATR) 1.23 0.50
MACD -0.08 -0.05
Stochastic Oscillator 61.52 61.53

Price Performance

Historical Comparison
MXL
VIR

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: